Status:
UNKNOWN
Application of Integrated MR-PET in Patients With Gynecologic Cancers
Lead Sponsor:
National Taiwan University Hospital
Conditions:
MR-PET Imaging
Eligibility:
FEMALE
20-90 years
Brief Summary
In this prospective cohort study, patients with newly diagnosed gynecologic cancers (including cervical, endometrial, and ovarian cancers) and patients with suspicious recurrent gynecologic cancers wi...
Eligibility Criteria
Inclusion
- Group 1: Patients with newly diagnosed gynecologic cancers (including cervical, endometrial, and ovarian cancers).
- Group 2: Patients with suspicious recurrent gynecologic cancers (including cervical, endometrial, and ovarian cancers).
- Group 3: Patients with ovarian cancer who had debulking surgery and are going to receive adjuvant chemotherapy.
Exclusion
- Age \<20 or \>90 years old
- Contraindication for MRI:
- Contraindication for MR contrast medium (Cre \> 2.0)
- History of other malignancy
- Prior arthroplasty of hip or pelvic bone surgery with metallic fixation (may cause artifacts on MRI)
- Pregnant or lactating women
Key Trial Info
Start Date :
April 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT02292615
Start Date
April 1 2014
Last Update
November 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100